The question of whether these agents can be safely used together requires careful consideration of pharmacological properties, clinical evidence, and FDA guidance regarding thyroid-related safety concerns specific to GLP-1 receptor agonists
In regards to the current GLP-1 medication shortage, Cutler said this is a topic and a struggle he deals with on a daily basis
Why did the thought of my favorite pasta make me feel queasy
To be a candidate for a weight loss peptide, namely a GLP-1 RA, you typically need to meet one or several of the following diagnostic criteria: Obesity: Obesity is defined as having a body mass index (BMI) above 30 (e.g., someone whos 511 and weighs 215lb would qualify as obese),22 but a BMI slightly below 30 doesnt disqualify you for a peptide prescription
Most Common Side Effects These are the side effects most frequently reported in clinical studies: Nausea (feeling sick) Vomiting Diarrhoea Constipation Abdominal discomfort or bloating Decreased appetite Fatigue or mild tiredness Headaches These effects are similar to those seen with other weight-loss injections that act on gut hormones and are typically digestive (gastrointestinal) symptoms
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: a post hoc analysis
